Filing Details

Accession Number:
0000885590-11-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-13 13:48:17
Reporting Period:
2011-05-11
Filing Date:
2011-05-13
Accepted Time:
2011-05-13 13:48:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477126 Andrew Mark Durham C/O 7150 Mississauga Road
Mississauga A6 L5N 8M5
Svp Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2011-05-11 50,000 $24.50 111,595 No 4 M Direct
Common Stock, No Par Value Disposition 2011-05-11 50,000 $52.17 61,595 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, No Par Value Stock Options (right to purchase) Disposition 2011-05-11 50,000 $0.00 50,000 $24.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-03-01 2011-05-25 No 4 M Direct
Footnotes
  1. The reporting person is exercising stock options that were set to expire on May 25, 2011 if unexercised.